Cited by 181Signaling Pathways in DiseaseMitochondrial Function and PathologyCell death mechanisms and regulation

Mitochondrial Targeted Cyclophilin D Protects Cells from Cell Death by Peptidyl Prolyl Isomerization

Open access
Lin, Da-Ting, Lechleiter, James D.·2002·Journal of Biological Chemistry

Abstract

Cyclophilin D (CyPD) is thought to sensitize opening of the mitochondrial permeability transition pore (mPTP) based on the findings that cyclosporin A (CsA), a pseudo-CyPD substrate, hyperpolarizes the mitochondrial membrane potential (DeltaPsi) and inhibits apoptosis. We provide evidence that contrasts with this model. Using live cell imaging and two photon microscopy, we report that overexpression of CyPD desensitizes HEK293 and rat glioma C6 cells to apoptotic stimuli. By site-directed mutagenesis of CyPD that compromises peptidyl-prolyl cis-trans isomerase (PPIase) activity, we demonstrate that the mechanism involved in this protective effect requires PPIase activity. Furthermore, we show that, under resting conditions, DeltaPsi is hyperpolarized in CyPD wild type-overexpressing cells but not in cells overexpressing mutant forms of CyPD that lack PPIase activity. Finally, in glutathione S-transferase (GST) pull-down assays, we demonstrate that CyPD binding to the adenine nucleotide translocator (ANT), which is considered to be the core component of the mPTP, is not affected by the loss of PPIase activity. Collectively, our data suggest that CyPD should be viewed as a cell survival-signaling molecule and indicate a protective role of CyPD against apoptosis that is mediated by one or more targets other than the ANT.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m112035200

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cyclosporine A acts as an MPT inhibitor by preventing CyPD from interacting with MPTP.

    “Cyclosporine A (CsA), a pseudosubstrate of CyPD (Lin and Lechleiter, 2002), keeps CyPD from interacting with MPTP then acts as an MPT inhibitor (Broekemeier et al., 1989).”

    From Mitochondrial Dysfunction Induced by Sertraline, an Antidepressant Agent (2012) · cites this paper as Lin and Lechleiter, 2002

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 57 · Cited by 181

Research works printed but not linked: 3

  1. Ke, H., Mayrose, D., and Cao, W. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 3324 -3328
  2. Halestrap, A. P., Doran, E., Gillespie, J. P., and O'Toole, A. (2000) Biochem. Soc. Trans. 28, 170 -177
  3. Davis, E. S., Becker, A., Heitman, J., Hall, M. N., and Brennan, M. B. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 11169 -11173

Authors
Lin, D.-T., & Lechleiter, J. D.
Affiliations
The University of Texas at San Antonio Health Science Center (US)
Corresponding author
Lechleiter, James D.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2002-08
Volume
277
Issue
34
Pages
31134-31141
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2023555853
Cited by
181
References
57
Citations by year
2026: 1 · 2025: 5 · 2024: 2 · 2023: 5 · 2022: 15 · 2021: 8 · 2020: 5 · 2019: 1 · 2018: 3 · 2017: 10 · 2016: 11 · 2015: 9 · 2014: 9 · 2013: 7 · 2012: 8
FWCI
4.07
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • University of Texas Health Science Center at San Antonio
  • National Institute of General Medical Sciences (GM 48451, R01GM048451)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords
cyclophilin D, peptidyl-prolyl isomerase, apoptosis, mitochondrial permeability transition pore, mitochondrial membrane potential, adenine nucleotide translocase, cell survival signaling, cyclosporine, mitochondrial hyperpolarization, glioma cells, HEK293 cells
MeSH terms
Peptidyl-Prolyl Isomerase F, Mitochondrial Permeability Transition Pore, Mitochondrial ADP, ATP Translocases, Animals, Binding Sites, Humans, Ion Channels, Membrane Potentials, Cyclosporine, Apoptosis, Oxidative Stress, Staurosporine, Peptidylprolyl Isomerase, tert-Butylhydroperoxide, Cyclophilins, Mitochondrial Membrane Transport Proteins, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review